JORDYN POPPLE: Open Payments
NPI 1306463997 · SYOSSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 24 payments from 9 companies in 2025. Trend: 2023 $808 · 2024 $1,967 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $198 |
| Regeneron Healthcare Solutions, Inc. | 6 | $139 |
| Optinose US, Inc. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Invivyd Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: DUPIXENT, Xhance, Rhapsido, PEMGARDA, ZEPBOUND, CAPVAXIVE, Ryaltris, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
